As part of the MAN 633 Entrepreneurial Spirit Thiago Cäsar joined Cansativa in fall semester 2019. His mission was to develop a European Expansion strategy for the company. The goal of this project was to develop a framework for a prospective market entry of Cansativa into other European markets and the question which type of market entry strategy should be applied for a certain market. Therefore, a multiplicity of different market aspects with very heterogeneous specifications had to be prioritized, categorized and benchmarked in order to achieve a minimum level of comparability between the most relevant European markets for medical cannabis. Based on the legal and commercial attractivity nine different market scenarios were derived and respective market entry strategies suggested.
Cansativa was founded in 2017. The startup from near Frankfurt is a pharmaceutical company that is distributing medical cannabis to pharmacies throughout Germany and that position itself as a central entry gate to Europe for medical cannabis producers from all around the world. Cannabis could be applied also for medical reasons due to the broad application range and it’s remarkable effects.
Learn more on https://www.cansativa.de